• Citer

Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).

par Abdel Azim, Hatem Hamdy ;Metzger-Filho, Otto;de Azambuja, Evandro ;Loibl, Sibylle;Focant, Florine;Gresko, Ekaterina;Arfi, Mounir;Piccart-Gebhart, Martine
Référence Breast cancer research and treatment, 133, 1, page (387-391)
Publication Publié, 2012-05

Article révisé par les pairs

• Détails
• Contenu

Titre:	Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
Auteur:	Abdel Azim, Hatem Hamdy; Metzger-Filho, Otto; de Azambuja, Evandro; Loibl, Sibylle; Focant, Florine; Gresko, Ekaterina; Arfi, Mounir; Piccart-Gebhart, Martine
Informations sur la publication:	Breast cancer research and treatment, 133, 1, page (387-391)
Statut de publication:	Publié, 2012-05
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Counseling
	Fetal outcome
	Pregnancy
	Trastuzumab
MeSH keywords:	Abnormalities, Drug-Induced -- etiology
	Abortion, Spontaneous -- chemically induced
	Adult
	Antibodies, Monoclonal, Humanized -- adverse effects -- therapeutic use
	Antineoplastic Agents -- adverse effects -- therapeutic use
	Breast Neoplasms -- drug therapy
	Chemotherapy, Adjuvant
	Clinical Trials, Phase III as Topic
	Female
	Humans
	Pregnancy
	Pregnancy Complications, Neoplastic -- drug therapy
	Randomized Controlled Trials as Topic
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-012-1996-6
	info:scp/84860330520
	info:pmid/22367645